We observed a significant trend of an association between IBD classification and the response to molecular-targeted therapy.
← all excerpts
Machine Learning of Serum Cytokine and Chemokine Profiles Can Classify Inflammatory Bowel Disease Beyond Clinical Diagnosis.
1
—
—